- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06109480
Effect of HD-tDCS Assisted ECT for Depression Disorder
Effect of High Definition Transcranial Direct Current Stimulation (HD-tDCS) Assisted Electroconvulsive Therapy (ECT) for Depression Disorder
Study Overview
Status
Detailed Description
Depression is a mental disorder characterized by low mood, decreased interest, and reduced activity. It affects approximately 350 million people around the world and has become a major public health and social problem. Electroconvulsive therapy (ECT) can quickly and effectively improve depressive symptoms, but it causes severe impairment of cognitive functions, such as reduced face memory. Therefore, improving treatment options is of great significance.
Electroconvulsive therapy depends on the number of treatments, usually 2-3 times a week, for a total of 6-12 treatments. Studies have shown early mood improvement after the third ECT. The investigators propose a new ECT treatment strategy, which involves sequential hybridization of high definition transcranial direct current stimulation (HD-tDCS) after the third ECT to maintain its efficacy while mitigating cognitive side effects.
60 patients with depressive disorder diagnosed by Diagnostic and Statistical Manual of Mental Disorders(DSM-5) were recruited from the fourth people's Hospital of Hefei and the Second Hospital of Anhui Medical University. All participants underwent a structured interview and routine laboratory examination before treatments. After meeting the inclusion criteria and obtaining informed consent, All the participants were randomized (1:1:1) into three groups: ECT combined with real stimulation tDCS group, ECT combined with sham stimulation tDCS group, and ECT full course group.
For ECT combined with real stimulation tDCS group, Bifrontal short-pulse ECT was performed once a day for 3 consecutive days. Then,tDCS stimulates the dorsomedial prefrontal cortex. The anode was placed over Fz with return electrodes placed at Fpz, Cz, F3 and F4. 2 milliampere(mA) (ramp-up and ramp-down periods of 30 and 30 seconds, respectively) were applied for 20 minutes Twice a day over 10 consecutive sessions.
For ECT combined with sham stimulation tDCS group,Bifrontal short-pulse ECT was performed once a day for 3 consecutive days.Then,Sham HD-tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.
For ECT full course group,Bifrontal short-pulse ECT was performed once a day for 3 consecutive days, then once every other day, for a total of 6 times,as a traditional contrast Emotional and memory function assessments were conducted at three time points: baseline, post-ECT, and post-TDCS. Emotional assessments included Hamilton Rating Scale for Depression(HAMD), Hamilton Anxiety Scale(HAMA), Beck Scale For Suicide Ideation(BSS), Patient Health Questionnaire-15(PHQ15), Ruminative Responses Scale(RRS), The Temporal Experience of Pleasure Scale (TEPS) and The Positive and Negative Affect Scale(PANAS). Memory function assessments included association memory and working memory.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kai Wang, PhD
- Phone Number: +86-0551-62923704
- Email: wangkai1964@126.com
Study Contact Backup
- Name: Yanghua Tian, PhD
- Phone Number: +8613955188448
- Email: ayfytyh@126.com
Study Locations
-
-
-
Hefei, China
- Recruiting
- Anhui Medical University
-
Contact:
- Kai Wang, PhD
- Phone Number: +86055162923704
- Email: wangkai1964@126.com
-
Contact:
- Yanghua Tian, PhD
- Phone Number: +86055162923704
- Email: ayfytyh@126.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- the patients were diagnosed by more than 2 psychiatrists and met the diagnostic criteria of DSM-5 for depression, and HAMD>17.
- Meets the ECT treatment indication
- the age ranged from 18 to 60 years old, and the length of education was more than 5 years.
- the visual acuity or corrected visual acuity is normal, right-handed, can cooperate with the completion of various experimental tests.
Exclusion Criteria:
- accompanied by severe somatic diseases, such as severe heart, liver, renal insufficiency and so on.
- accompanied by other neurological diseases, such as stroke, epilepsy and so on. pregnant and lactating women.
- accompanied by other mental disorders, such as drug abuse, schizophrenia, schizophrenic affective disorder, hysteria, autism and so on.
- with a history of ECT treatment within the past 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: ECT combined with real stimulation tDCS group
Bifrontal short-pulse ECT was performed once a day for 3 consecutive days.
Then,tDCS stimulates the dorsomedial prefrontal cortex.
The anode was placed over Fz with return electrodes placed at Fpz, Cz, F3 and F4.
2-mA (ramp-up and ramp-down periods of 30 and 30 seconds, respectively) were applied for 20 minutes Twice a day over 10 consecutive sessions.
|
tDCS is described as a non-invasive form of brain stimulation that uses a low-intensity, constant current applied directly to the head through scalp electrodes.
ECT induces brief generalized epileptic seizures by electric current to stimulate the forehead under general anesthesia
|
|
Sham Comparator: ECT combined with sham stimulation tDCS group
Bifrontal short-pulse ECT was performed once a day for 3 consecutive days.
Then,Sham HD-tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.
|
ECT induces brief generalized epileptic seizures by electric current to stimulate the forehead under general anesthesia
Sham HD-tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.
|
|
Other: ECT full course group
The ECT full corse group was used as a standard control.Bifrontal short-pulse ECT was performed once a day for 3 consecutive days,and then once every other day, for a total of 6 times.
|
ECT induces brief generalized epileptic seizures by electric current to stimulate the forehead under general anesthesia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hamilton Depression Rating Scale (HAMD) Score
Time Frame: baseline, the third day(immediately after the ECT intervention),the eighth day(immediately after the tDCS intervention)
|
The HAMD is a clinician-administered depression assessment and consists of 17 items with a total score range from 0 to 54.
A higher score indicates a worse outcome.
|
baseline, the third day(immediately after the ECT intervention),the eighth day(immediately after the tDCS intervention)
|
|
Change in Associative Memory
Time Frame: baseline, the third day(immediately after the ECT intervention),the eighth day(immediately after the tDCS intervention)
|
The associative memory was estimated using a face-cued word association test.
In the face-cued word association test, participants studied 12 human face photographs presented individually in grayscale on a computer screen for 4 s per face.
Each photograph displayed a unique common word that the participants read aloud as each face-word pair was shown.
The participants were instructed to memorize the word associated with each face.
After the face-word pairs were presented, participants were shown the same 12 faces, individually and in a different and randomized order.
They were asked to recall the words that were presented with each face.
Each face was scored as correct or incorrect.These processes are carried out 2 times in total.The average number of successful answers was defined as the associative memory score.
|
baseline, the third day(immediately after the ECT intervention),the eighth day(immediately after the tDCS intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hamilton Anxiety Scale (HAMA) Score
Time Frame: baseline, the third day(immediately after the ECT intervention),the eighth day(immediately after the tDCS intervention)
|
The HAMA is a 14-item scale to measure the severity of anxiety symptoms, where each item is rated on a scale from 0 to 4. The HAMA total score ranges from 0 to 56, with lower scores indicating less anxiety symptoms.
|
baseline, the third day(immediately after the ECT intervention),the eighth day(immediately after the tDCS intervention)
|
|
Change in the Patient Health Questionnaire-15 (PHQ-15) scale
Time Frame: baseline, the third day(immediately after the ECT intervention),the eighth day(immediately after the tDCS intervention)
|
The PHQ-15 is a 15-item scale to measure the severity of somatic symptoms, where each item is rated on a scale from 0 to 2. The PHQ-15 total score ranges from 0 to 30, with lower scores indicating less somatic symptoms.
|
baseline, the third day(immediately after the ECT intervention),the eighth day(immediately after the tDCS intervention)
|
|
Change in Working Memory
Time Frame: baseline, the third day(immediately after the ECT intervention),the eighth day(immediately after the tDCS intervention)
|
The n-back task is one of the most common tasks in working memory studies, involving the storage and manipulation of information.
In the 2-back condition, they were required to press a button when the current stimulus matched the stimulus from two trials back; in the 1-back condition, participants pressed a button if the current stimulus matched the immediately preceding stimulus.The n-back task consisted of two block-design functional runs, each of which lasted 336 s.Each run included four block sets, where the 1-back and 2-back conditions were intermixed.
The order of blocks in each run was pseudorandomized across participants.The average correct rate in the two conditions was used as an indicator of working memory.
|
baseline, the third day(immediately after the ECT intervention),the eighth day(immediately after the tDCS intervention)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Yanghua Tian, PhD, Anhui Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AHMU-ECT-TDCS-MDD
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Disorder
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
Sheba Medical CenterNot yet recruiting
-
Rotman Research Institute at BaycrestRecruitingMajor Depressive Disorder (MDD)Canada
-
ACADIA Pharmaceuticals Inc.RecruitingACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response (NORLIGHT)Depressive Disorder, Treatment-Resistant | Major Depressive Disorder (MDD)United States
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingDepression - Major Depressive Disorder | Depression Chronic | Treatment-Resistant Major Depressive Disorder | Depression DisorderSpain
-
The Royal Ottawa Mental Health CentreNot yet recruitingDepression | Major Depressive Disorder (MDD) | Depressive Episode | Depression - Major Depressive DisorderCanada
-
Stanford UniversityNational Institute of Mental Health (NIMH)Recruiting
-
TakedaRecruitingMajor Depressive DisorderJapan
-
Neurocrine BiosciencesRecruitingMajor Depressive DisorderSpain, Serbia, United States, Bulgaria, Canada, Estonia, Italy, Poland, Taiwan, Australia, South Korea
-
Luye Pharma Group Ltd.Enrolling by invitationMajor Depressive DisorderChina
Clinical Trials on High definition transcranial direct current stimulation
-
Anhui Medical UniversityCompletedDepressive Disorder | Functional Magnetic Resonance Imaging | Transcranial Direct Current StimulationChina
-
Anhui Medical UniversityRecruitingAnxiety | Magnetic Resonance Imaging | Transcranial Direct Current StimulationChina
-
The University of Texas at DallasUniversity of Texas Southwestern Medical CenterCompletedMemory Disorders | Word Finding DifficultyUnited States
-
South China Normal UniversityCompletedSocial Anxiety DisorderChina
-
Nanjing Medical UniversityNot yet recruitingAnxiety Disorders | High-definition Transcranial Direct Current StimulationChina
-
University of Texas Rio Grande ValleyActive, not recruitingSpinal Cord Diseases | Spinal Cord InjuriesUnited States
-
Anhui Medical UniversityRecruitingTranscranial Direct Current Stimulation | Non Suicidal Self InjuryChina
-
WANG KAICompletedHealthy Adults | Transcranial Direct Current StimulationChina
-
Istituti Clinici Scientifici Maugeri SpAUniversity of Palermo; University of Milano Bicocca; IRCCS ISMETT PalermoRecruiting
-
Anhui Medical UniversityRecruitingTranscranial Magnetic Stimulation | Functional Magnetic Resonance Imaging | Refractory Epilepsy | Transcranial Direct Current Stimulation | EEGChina